This clinical trial tests how well a therapy approach intervention (FearLess) works to decrease fear of cancer coming back (recurrence) in patients with stage II-IV glioma. FearLess includes psychotherapy techniques varying from relaxation response to self-regulation targeted to the specific fears. This trial may help researchers better understand the potential benefits of this intervention in improving mood, quality of life, and how best to revise the program.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05604365.
PRIMARY OBJECTIVES:
I. Determine feasibility of FearLess in cognitively intact patients with glioma.
II. Determine acceptability of FearLess in cognitively intact patients with glioma.
III. Using qualitative inquiry, further optimize the FearLess intervention and research procedures for cognitively intact patients with glioma.
OUTLINE: Patients and caregivers are assigned to 1 of 3 arms.
ARM I: Patients participate in FearLess program sessions on study.
ARM II: Patients and caregivers participate in FearLess program sessions on study.
ARM III: Caregivers participate in FearLess program sessions on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationVCU Massey Comprehensive Cancer Center
Principal InvestigatorAshlee R Loughan